{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:26:25Z","timestamp":1793834785634,"version":"4.6.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s13304-025-02509-2","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T16:35:34Z","timestamp":1770050134000},"page":"2733-2742","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the frontier: promising survival in selected patients after CRS and HIPEC for peritoneal metastases from hepatocellular carcinoma\u2014a systematic review"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8040-2231","authenticated-orcid":false,"given":"Federica","family":"Ferracci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2050-3815","authenticated-orcid":false,"given":"Carlo","family":"Abatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2007-0969","authenticated-orcid":false,"given":"Miriam Attalla El","family":"Halabieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Lodoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2791-510X","authenticated-orcid":false,"given":"Francesco","family":"Santullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"2509_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"2509_CR2","unstructured":"National Comprehensive Cancer Network (2025) Hepatocellular carcinoma. Version 1.2025. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae). March 20, 2025. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/hcc.pdf. Accessed April 6"},{"key":"2509_CR3","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.surg.2014.07.024","volume":"157","author":"AWC Kow","year":"2015","unstructured":"Kow AWC, Kwon CHD, Song S, Kim JM, Joh JW (2015) Clinicopathological factors and long-term outcome comparing between lung and peritoneal metastasectomy after hepatectomy for hepatocellular carcinoma in a tertiary institution. Surgery 157:645\u2013653. https:\/\/doi.org\/10.1016\/j.surg.2014.07.024","journal-title":"Surgery"},{"key":"2509_CR4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378\u2013390. https:\/\/doi.org\/10.1056\/NEJMoa0708857","journal-title":"N Engl J Med"},{"key":"2509_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.21037\/jgo.2016.09.07","volume":"8","author":"DW Kim","year":"2017","unstructured":"Kim DW, Talati C, Kim R (2017) Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy. J Gastrointest Oncol 8:256\u2013265. https:\/\/doi.org\/10.21037\/jgo.2016.09.07","journal-title":"J Gastrointest Oncol"},{"key":"2509_CR6","doi-asserted-by":"publisher","first-page":"314","DOI":"10.21037\/jgo.2016.09.17","volume":"8","author":"J Gong","year":"2017","unstructured":"Gong J, Cho M, Fakih M (2017) Chemotherapy in patients with hepatobiliary cancers and abnormal hepatic function. J Gastrointest Oncol 8:314\u2013323. https:\/\/doi.org\/10.21037\/jgo.2016.09.17","journal-title":"J Gastrointest Oncol"},{"key":"2509_CR7","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","volume":"17","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Arvieux C, Cotte E, Boutitie F, Mansvelt B et al (2010) Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 17:2370\u20132377. https:\/\/doi.org\/10.1245\/s10434-010-1039-7","journal-title":"Ann Surg Oncol"},{"key":"2509_CR8","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1002\/cncr.32881","volume":"126","author":"D Schuitevoerder","year":"2020","unstructured":"Schuitevoerder D, Plana A, Izquierdo FJ, Votanopoulos KI, Cusack JC, Bijelic L et al (2020) The Chicago consensus on peritoneal surface malignancies: management of appendiceal neoplasms. Cancer 126:2525\u20132533. https:\/\/doi.org\/10.1002\/cncr.32881","journal-title":"Cancer"},{"key":"2509_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4149\/BLL_2023_052","volume":"124","author":"D Klos","year":"2023","unstructured":"Klos D, Hanuliak J, Lemstrova R, Mohelnikovaduchonova B, Zapletalova J, Melichar B et al (2023) Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma. Bratisl Lek Listy 124:345\u2013350. https:\/\/doi.org\/10.4149\/BLL_2023_052","journal-title":"Bratisl Lek Listy"},{"key":"2509_CR10","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20:1248\u20131259. https:\/\/doi.org\/10.1200\/JCO.2002.20.5.1248","journal-title":"J Clin Oncol"},{"key":"2509_CR11","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1055-3207(03)00029-2","volume":"12","author":"RP Sticca","year":"2003","unstructured":"Sticca RP, Dach BW (2003) Rationale for hyperthermia with intraoperative intraperitoneal chemotherapy agents. Surg Oncol Clin N Am 12:689\u2013701. https:\/\/doi.org\/10.1016\/S1055-3207(03)00029-2","journal-title":"Surg Oncol Clin N Am"},{"key":"2509_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/1471-2407-6-162","volume":"6","author":"JOW Pelz","year":"2006","unstructured":"Pelz JOW, Doerfer J, Dimmler A, Hohenberger W, Meyer T (2006) Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations. BMC Cancer 6:162. https:\/\/doi.org\/10.1186\/1471-2407-6-162","journal-title":"BMC Cancer"},{"key":"2509_CR13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s00268-003-7319-7","volume":"28","author":"CN Yeh","year":"2004","unstructured":"Yeh CN, Chen MF (2004) Resection of peritoneal implantation of hepatocellular carcinoma after hepatic resection: risk factors and prognostic analysis. World J Surg 28:382\u2013386. https:\/\/doi.org\/10.1007\/s00268-003-7319-7","journal-title":"World J Surg"},{"key":"2509_CR14","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.3748\/wjg.15.5481","volume":"15","author":"KM Chan","year":"2009","unstructured":"Chan KM, Yu MC, Wu TJ, Lee CF, Chen TC, Lee WC et al (2009) Efficacy of surgical resection in management of isolated extrahepatic metastases of hepatocellular carcinoma. World J Gastroenterol 15:5481\u20135487. https:\/\/doi.org\/10.3748\/wjg.15.5481","journal-title":"World J Gastroenterol"},{"key":"2509_CR15","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1440-1746.2009.05848.x","volume":"24","author":"CC Lin","year":"2009","unstructured":"Lin CC, Liang HP, Lee HS, Huang GT, Yang PM, Ho MC et al (2009) Clinical manifestations and survival of hepatocellular carcinoma patients with peritoneal metastasis. J Gastroenterol Hepatol 24:815\u2013820. https:\/\/doi.org\/10.1111\/j.1440-1746.2009.05848.x","journal-title":"J Gastroenterol Hepatol"},{"key":"2509_CR16","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/jso.23739","volume":"110","author":"P Tabrizian","year":"2014","unstructured":"Tabrizian P, Franssen B, Jibara G, Sweeney R, Sarpel U, Schwartz M et al (2014) Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with peritoneal hepatocellular carcinoma. J Surg Oncol 110:786\u2013792. https:\/\/doi.org\/10.1002\/jso.23739","journal-title":"J Surg Oncol"},{"key":"2509_CR17","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.5301\/tj.5000197","volume":"101","author":"SB Bhagwandin","year":"2015","unstructured":"Bhagwandin SB, Salti GI (2015) Hepatocellular carcinoma with peritoneal metastasis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. Tumori 101:e1\u20133. https:\/\/doi.org\/10.5301\/tj.5000197","journal-title":"Tumori"},{"key":"2509_CR18","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN et al (2012) Early- and long-term outcome data of patients with Pseudomyxoma peritonei from appendiceal origin treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30:2449\u20132456. https:\/\/doi.org\/10.1200\/JCO.2011.39.7166","journal-title":"J Clin Oncol"},{"key":"2509_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/jso.24340","volume":"114","author":"Y Berger","year":"2016","unstructured":"Berger Y, Spivack JH, Heskel M, Aycart SN, Labow DM, Sarpel U (2016) Extrahepatic metastasectomy for hepatocellular carcinoma: predictors of long-term survival. J Surg Oncol 114:469\u2013474. https:\/\/doi.org\/10.1002\/jso.24340","journal-title":"J Surg Oncol"},{"key":"2509_CR20","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1016\/j.ejso.2018.05.021","volume":"44","author":"S Mehta","year":"2018","unstructured":"Mehta S, Schwarz L, Spiliotis J, Hsieh MC, Akaishi EH, Goere D et al (2018) Is there an oncological interest in the combination of CRS\/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study. Eur J Surg Oncol 44:1786\u20131792. https:\/\/doi.org\/10.1016\/j.ejso.2018.05.021","journal-title":"Eur J Surg Oncol"},{"key":"2509_CR21","doi-asserted-by":"publisher","first-page":"20190030","DOI":"10.1515\/pp-2019-0030","volume":"5","author":"KC Hung","year":"2020","unstructured":"Hung KC, Yang KL, Huang GC, Chen YF, Chang WT, Lin CC et al (2020) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treating advanced peritoneal metastases of hepatocellular carcinoma. Pleura Peritoneum 5:20190030. https:\/\/doi.org\/10.1515\/pp-2019-0030","journal-title":"Pleura Peritoneum"},{"key":"2509_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jviscsurg.2015.11.010","volume":"153","author":"C Honor\u00e9","year":"2016","unstructured":"Honor\u00e9 C, Go\u00e9r\u00e9 D, Macovei R, Colace L, Benhaim L, Elias D (2016) Peritoneal carcinomatosis from unusual cancer origins: is there a role for hyperthermic intraperitoneal chemotherapy? J Visc Surg 153:101\u2013107. https:\/\/doi.org\/10.1016\/j.jviscsurg.2015.11.010","journal-title":"J Visc Surg"},{"key":"2509_CR23","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ et al (eds) (2023) Cochrane handbook for systematic reviews of interventions. Version 6.4. London: Cochrane; Available at: https:\/\/training.cochrane.org\/handbook\/current. Accessed April 8, 2025"},{"key":"2509_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1\u20139. https:\/\/doi.org\/10.1186\/2046-4053-4-1","journal-title":"Syst Rev"},{"key":"2509_CR25","unstructured":"PROSPERO. International Prospective Register of Systematic Reviews (2025) Available at: https:\/\/www.crd.york.ac.uk\/prospero\/. Accessed April 8"},{"key":"2509_CR26","unstructured":"Ferracci F, Santullo F (2024) Exploring the frontier: a systematic review of the role of CRS and HIPEC for hepatocellular carcinoma treatment. PROSPERO Registration number CRD42024627130"},{"key":"2509_CR27","first-page":"20","volume":"1","author":"J Spiliotis","year":"2017","unstructured":"Spiliotis J, Nikolaou G, Kopanakis N, Vassiliadou D, Terra A, Efstathiou E (2017) Hepatocellular carcinoma peritoneal metastasis: role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Gulf J Oncol 1:20\u201323","journal-title":"Gulf J Oncol"},{"key":"2509_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12957-020-01898-5","volume":"18","author":"N Leigh","year":"2020","unstructured":"Leigh N, Solomon D, Pletcher E, Labow DM, Magge DR, Sarpel U et al (2020) Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies? World J Surg Oncol 18:253. https:\/\/doi.org\/10.1186\/s12957-020-01898-5","journal-title":"World J Surg Oncol"},{"key":"2509_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12957-024-03426-1","volume":"22","author":"G Yan","year":"2024","unstructured":"Yan G, Zhang K, Yan L, Zhang Y (2024) Long-term survival outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastasis of hepatocellular carcinoma patients. World J Surg Oncol 22:144. https:\/\/doi.org\/10.1186\/s12957-024-03426-1","journal-title":"World J Surg Oncol"},{"key":"2509_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187\u2013196. https:\/\/doi.org\/10.1097\/SLA.0b013e3181b13ca2","journal-title":"Ann Surg"},{"key":"2509_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.SLA.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205\u2013213. https:\/\/doi.org\/10.1097\/01.SLA.0000133083.54934.ae","journal-title":"Ann Surg"},{"key":"2509_CR32","volume-title":"Common terminology criteria for adverse events (CTCAE) v5.0","author":"National Cancer Institute","year":"2017","unstructured":"National Cancer Institute (2017) Common terminology criteria for adverse events (CTCAE) v5.0. U.S. Department of Health and Human Services, Bethesda, MD"},{"key":"2509_CR33","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jamcollsurg.2003.07.003","volume":"197","author":"C Cha","year":"2003","unstructured":"Cha C, Fong Y, Jarnagin WR, Blumgart LH, DeMatteo RP (2003) Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg 197:753\u2013758. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2003.07.003","journal-title":"J Am Coll Surg"},{"key":"2509_CR34","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/ases.12212","volume":"8","author":"S Hai","year":"2015","unstructured":"Hai S, Okada T, Iimuro Y, Hirano T, Suzumura K, Fujimoto J (2015) Successful laparoscopic extirpation of peritoneal dissemination after hepatectomy for ruptured hepatocellular carcinoma. Asian J Endosc Surg 8:465\u2013467. https:\/\/doi.org\/10.1111\/ases.12212","journal-title":"Asian J Endosc Surg"},{"key":"2509_CR35","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.3748\/wjg.14.3927","volume":"14","author":"MC Hung","year":"2008","unstructured":"Hung MC, Wu HS, Lee YT, Hsu CH, Chou DA, Huang MH et al (2008) Intraperitoneal metastasis of hepatocellular carcinoma after spontaneous rupture: a case report. World J Gastroenterol 14:3927\u20133931. https:\/\/doi.org\/10.3748\/wjg.14.3927","journal-title":"World J Gastroenterol"},{"key":"2509_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ccr3.50","volume":"2","author":"T Kitajima","year":"2014","unstructured":"Kitajima T, Hashimoto M, Sasaki K, Matsuda M, Kuroda Y, Fujii T et al (2014) Long-term survival after two surgical resections of peritoneal metastases from hepatocellular carcinoma with an interval of 4 years. Clin Case Rep 2:37\u201341. https:\/\/doi.org\/10.1002\/ccr3.50","journal-title":"Clin Case Rep"},{"key":"2509_CR37","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s005350200089","volume":"37","author":"K Kurachi","year":"2002","unstructured":"Kurachi K, Suzuki S, Yokoi Y, Okumura T, Inaba K, Igarashi T et al (2002) A 5-year survivor after resection of peritoneal metastases from pedunculated-type hepatocellular carcinoma: a case report. J Gastroenterol 37:571\u2013574","journal-title":"J Gastroenterol"},{"key":"2509_CR38","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/jjco\/hyh096","volume":"34","author":"H Takahashi","year":"2004","unstructured":"Takahashi H, Konishi M, Nakagohri T, Inoue K, Takahashi S, Tanizawa Y et al (2004) Aggressive multimodal treatment for peritoneal dissemination and needle tract implantation of hepatocellular carcinoma: a case report. Jpn J Clin Oncol 34:551\u2013555. https:\/\/doi.org\/10.1093\/jjco\/hyh096","journal-title":"Jpn J Clin Oncol"},{"key":"2509_CR39","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1046\/j.1440-1746.2000.02092.x","volume":"15","author":"T Terasaki","year":"2000","unstructured":"Terasaki T, Hanazaki K, Shiohara E, Matsunaga Y, Koide N, Amano J (2000) Complete disappearance of recurrent hepatocellular carcinoma with peritoneal dissemination and Splenic metastasis: a unique clinical course after surgery. J Gastroenterol Hepatol 15:327\u2013330. https:\/\/doi.org\/10.1046\/j.1440-1746.2000.02092.x","journal-title":"J Gastroenterol Hepatol"},{"key":"2509_CR40","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O et al (2009) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 27:6237\u20136242. https:\/\/doi.org\/10.1200\/JCO.2009.23.9640","journal-title":"J Clin Oncol"},{"key":"2509_CR41","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.1002\/cncr.25356","volume":"116","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Boutitie F, Bereder JM, Quenet F, Sideris L et al (2010) Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1290 patients. Cancer 116:5608\u20135618. https:\/\/doi.org\/10.1002\/cncr.25356","journal-title":"Cancer"},{"key":"2509_CR42","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1016\/S1470-2045(12)70210-3","volume":"13","author":"PH Sugarbaker","year":"2012","unstructured":"Sugarbaker PH, Ryan DP (2012) Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach? Lancet Oncol 13:e362\u2013e369. https:\/\/doi.org\/10.1016\/S1470-2045(12)70210-3","journal-title":"Lancet Oncol"},{"key":"2509_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12957-015-0703-6","volume":"13","author":"M Cardi","year":"2015","unstructured":"Cardi M, Sammartino P, Mingarelli V, Sibio S, Accarpio F, Biacchi D et al (2015) Cytoreduction and HIPEC in the treatment of unconventional secondary peritoneal carcinomatosis. World J Surg Oncol 13:1. https:\/\/doi.org\/10.1186\/s12957-015-0703-6","journal-title":"World J Surg Oncol"},{"key":"2509_CR44","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY et al (2020) Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med 382:1894\u20131905. https:\/\/doi.org\/10.1056\/NEJMoa1915745","journal-title":"N Engl J Med"},{"key":"2509_CR45","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1245\/s10434-015-4627-8","volume":"23","author":"M Faron","year":"2016","unstructured":"Faron M, Macovei R, Go\u00e9r\u00e9 D, Honor\u00e9 C, Benhaim L, Elias D (2016) Linear relationship of peritoneal cancer index and survival in patients with peritoneal metastases from colorectal cancer. Ann Surg Oncol 23:114\u2013119. https:\/\/doi.org\/10.1245\/s10434-015-4627-8","journal-title":"Ann Surg Oncol"},{"key":"2509_CR46","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.3390\/jcm10214882","volume":"10","author":"A Rijken","year":"2021","unstructured":"Rijken A, Lurvink RJ, Luyer MDP, Nieuwenhuijzen GAP, van Erning FN, van Sandick JW et al (2021) The burden of peritoneal metastases from gastric cancer: a systematic review on the incidence, risk factors and survival. J Clin Med 10:4882. https:\/\/doi.org\/10.3390\/jcm10214882","journal-title":"J Clin Med"},{"key":"2509_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00423-023-03163-1","volume":"408","author":"F Santullo","year":"2023","unstructured":"Santullo F, Ferracci F, Abatini C, El Halabieh MA, Lodoli C, D\u2019Annibale G et al (2023) Gastric cancer with peritoneal metastases: a single-center outline and comparison of different surgical and intraperitoneal treatments. Langenbecks Arch Surg 408:1\u201310. https:\/\/doi.org\/10.1007\/s00423-023-03163-1","journal-title":"Langenbecks Arch Surg"},{"key":"2509_CR48","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.3390\/cancers13122964","volume":"13","author":"Y Kamada","year":"2021","unstructured":"Kamada Y, Hida K, Yonemura Y, Sugarbaker PH, Ghabra S, Ishihara S et al (2021) The characteristics of 206 long-term survivors with peritoneal metastases from colorectal cancer treated with curative intent surgery: a multi-center cohort from PSOGI. Cancers (Basel) 13:2964. https:\/\/doi.org\/10.3390\/cancers13122964","journal-title":"Cancers (Basel)"},{"key":"2509_CR49","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1245\/s10434-014-3693-7","volume":"21","author":"JF Le Brun","year":"2014","unstructured":"Le Brun JF, Campion L, Berton-Rigaud D, Lorimier G, Marchal F, Ferron G et al (2014) Survival benefit of hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer: a multi-institutional case\u2013control study. Ann Surg Oncol 21:3621\u20133627. https:\/\/doi.org\/10.1245\/s10434-014-3693-7","journal-title":"Ann Surg Oncol"},{"key":"2509_CR50","doi-asserted-by":"publisher","first-page":"e186847","DOI":"10.1001\/jamanetworkopen.2018.6847","volume":"2","author":"JM Foster","year":"2019","unstructured":"Foster JM, Sleightholm R, Patel A, Shostrom V, Hall B, Neilsen B et al (2019) Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures. JAMA Netw Open 2:e186847. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.6847","journal-title":"JAMA Netw Open"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-025-02509-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-025-02509-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-025-02509-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:07:01Z","timestamp":1793833621000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-025-02509-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2509"],"URL":"https:\/\/doi.org\/10.1007\/s13304-025-02509-2","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare they have no financial or non-financial interest for disclosure.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}